Evidence map›Paper›PMID 40773001›Full record

ReviewJapanese journal of ophthalmology2025

Dacryoendoscopy as a frontier technology for lacrimal drainage disorders.

Manabu Sugimoto, Yasushi Inoue, Atsushi Shiraishi

Abstract readReview
In one paragraph

Review in Japanese journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Manabu SugimotoSugimoto Eye Clinic, 158-5 Makabe, Soja City, Okayama, 719-1134, Japan. sugi-eye@hyper.ocn.ne.jp.
Yasushi InoueInoue Eye Clinic, Tamano, Okayama, Japan.
Atsushi ShiraishiDepartment of Ophthalmology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dacryocystorhinostomy (DCR) for adult patients with acquired nasolacrimal duct obstruction can be performed via 2 approaches: an external nasal approach from the skin and an internal nasal approach from the nasal cavity. Both techniques have a history of over 100 years and are the gold standard approaches for the treatment of nasolacrimal duct obstructions. Alternatively, researchers have also attempted lacrimal passage reconstruction using various stents to restore the patency of the lacrimal passage, with nunchaku-type silicone tubes showing good surgical results according to several published reports. However, in cases in which the procedure required blind manipulation, the results were largely dependent on the surgeon's skill. Under such circumstances, the dacryoendoscope was introduced at the beginning of this century and is currently widely used. In other fields, especially in gastroenterology, the introduction of gastrointestinal endoscopes that enable observation and treatment of lesions under direct observation has dramatically improved the treatment of gastrointestinal disorders. Considering that the dacryoendoscope has become standardized over the past 20 years since its introduction, this review summarizes the current status of lacrimal passage treatment using the dacryoendoscope.

Indexed as

DacryocystorhinostomyEndoscopyLacrimal Apparatus DiseasesLacrimal Duct ObstructionNasolacrimal DuctHumansStentsCanalicular obstructionCongenital nasolacrimal duct obstructionDacryoendoscopeLacrimal passage reconstruction surgeryNasolacrimal duct obstruction (NLDO)

Identifiers

PMID40773001
PMCPMC12391239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.